Borgohain, Rupam <br/><br/>
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Sep 2014 
 - 1273-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1531-8257 
<br/><br/><label>Standard No.: </label>10.1002/mds.25961  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alanine--analogs & derivatives<br/>Antiparkinson Agents--therapeutic use<br/>Benzylamines--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Dyskinesia, Drug-Induced<br/>Female<br/>Humans<br/>International Cooperation<br/>Levodopa--therapeutic use<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Parkinson Disease--drug therapy<br/>Treatment Outcome